Cargando…
TCT CONNECT-217 Hydroxychloroquine and Azithromycin Usage in African American Patients With Coronavirus Disease 2019 (COVID-19) and Their Effects on QT Interval
Autores principales: | Al-Sadawi, Mohammed, Budzikowski, Adam, Lee, Justin, Jallad, Ahmed, Sidiqi, Baho, Ibtida, Ishmam, Qaiser, Yusra, Chandrakumar, Harshith Priyan, Tadayoni, Ashkan, Madaj, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581319/ http://dx.doi.org/10.1016/j.jacc.2020.09.232 |
Ejemplares similares
-
QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020) -
Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020) -
Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19
por: O’Connell, Thomas F., et al.
Publicado: (2021) -
Reversible severe pulmonary hypertension and right heart failure with cardiogenic shock due to scurvy: a case report
por: Kurnick, Adam, et al.
Publicado: (2023) -
System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation
por: Khan, Abdul Arif, et al.
Publicado: (2020)